| 11/12/2026 3:09 PM | Pliant Therapeutics (1746473) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2026 3:11 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/02/2026 3:19 PM | Pliant Therapeutics (1746473) Issuer Raben David (2034679) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/02/2026 3:20 PM | Pliant Therapeutics (1746473) Issuer Raben David (2034679) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 8:31 PM | ADAR1 Capital Management, LLC (1940272) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 07/13/2026 3:25 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/13/2026 3:32 PM | Borellini Flavia (1867426) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/13/2026 3:32 PM | Borellini Flavia (1867426) Reporting Pliant Therapeutics (1746473) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/13/2026 3:32 PM | Iannone Robert (1737329) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/13/2026 3:32 PM | Iannone Robert (1737329) Reporting Pliant Therapeutics (1746473) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/12/2026 4:00 PM | Cline Darren S (1633639) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PLRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/12/2026 4:00 PM | Huh Hoyoung (1401267) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:01 PM | Curnutte John T (1574589) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:01 PM | Krognes Steve E. (1666236) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:01 PM | MCCOURT Thomas A (1478448) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 4:01 PM | CROWELL GAYLE A (1250893) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2026 3:52 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/22/2026 3:30 PM | Pliant Therapeutics (1746473) Filer | Form DEF 14A | |
| 04/22/2026 3:31 PM | Pliant Therapeutics (1746473) Filer | Form DEFA14A | |
| 04/22/2026 3:33 PM | Pliant Therapeutics (1746473) Filer | Form ARS | |
| 04/17/2026 3:42 PM | Cheung Lily (1962207) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:42 PM | Coulie Bernard (1808895) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:42 PM | Cummings Keith Lamont (1809204) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:42 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:30 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 11:15 PM | Pliant Therapeutics (1746473) Filer | Form EFFECT | |
| 03/11/2026 3:32 PM | Pliant Therapeutics (1746473) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 3:29 PM | Pliant Therapeutics (1746473) Subject Point72 Asset Management, L.P. (1603466) Filed by | Form SCHEDULE 13G/A | |
| 02/09/2026 5:13 PM | CITADEL ADVISORS LLC (1423053) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 01/30/2026 6:11 PM | CITADEL ADVISORS LLC (1423053) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 01/26/2026 3:36 PM | Coulie Bernard (1808895) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:36 PM | Cheung Lily (1962207) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:36 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:36 PM | Cummings Keith Lamont (1809204) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:38 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:38 PM | Coulie Bernard (1808895) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:38 PM | Cheung Lily (1962207) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:46 PM | Cummings Keith Lamont (1809204) Reporting Pliant Therapeutics (1746473) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 6:02 PM | CITADEL ADVISORS LLC (1423053) Filed by Pliant Therapeutics (1746473) Subject | Form SCHEDULE 13G | |
| 12/22/2025 4:02 PM | Kuo Minnie (2101360) Reporting Pliant Therapeutics (1746473) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/16/2025 4:05 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
A Nasdaq drone company just landed a deal with a Philippine billionaire's group (Ad) A Nasdaq-listed drone company just signed an exclusive agreement with Prime Strategic Holdings, part of billionaire Enrique Razon Jr.'s business empire. The Razon Group spans ports, energy, mining, utilities and infrastructure, and its affiliated port operator generated over $3.2 billion in 2025 revenue.
The deal lays the groundwork for drone manufacturing in the Philippines, with potential expansion across Southeast Asia. The company was also selected for a five-year Canadian Armed Forces contract covering 100 systems, with options for up to 4,900 more.
It supplies the U.S. Army, holds a U.S. Air Force Special Operations Command contract, and recently announced a $10 million strategic investment from Unusual Machines. See why this Nasdaq drone company is attracting attention and what comes next. |
| 12/08/2025 3:41 PM | Pliant Therapeutics (1746473) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |